Acceleron Pharma Inc Price to Earnings Ratio (PE) Ratios, (XLRN) Valuation Ranking and Trends, Fundamental Ratios - CSIMarket
CSIMarket
 




Acceleron Pharma inc  (NASDAQ: XLRN)
 





XLRN Price to Earnings Ratio Current (Jun 30 2021) (Mar 31 2021) (Dec 31 2020) (Sep 30 2020)
Diluted EPS 12 Trailing Months II. Quarter I. Quarter IV. Quarter III. Quarter
PE (TTM) Ratio current            -            -            -            -            -
Diluted EPS TTM Y / Y Change 77.92 % 45 % 17.69 % 23.85 % -11.11 %
Diluted EPS Y / Y Change 75.76 % 208.82 % 10.53 % 124.44 % -23.26 %
Stock performance to date 38.68 % -9.08 % 9.09 % 11.71 % 16.88 %

Price to earnings ratio Comment
Acceleron Pharma Inc's recorded net loss in trailing twelve months.

Within Healthcare sector 16 other companies have lower Price to earnings ratio.

What is Price to Earnings Ratio?
What is Acceleron Pharma Inc Market Share?

Price to earnings ratio Company Ranking
Within: No.
Industry #3
Sector #17
S&P 500 #50





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.